Terms: = Liver cancer AND ERBB4, MGC138404, 2066, ENSG00000178568, Q15303, p180erbB4, HER4
38 results:
1. Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis.
Lu X; Li Y; Li Y; Zhang X; Shi J; Feng H; Yu Z; Gao Y
BMC Cancer; 2023 Nov; 23(1):1117. PubMed ID: 37974093
[TBL] [Abstract] [Full Text] [Related]
2. The Yin and Yang of erbb4: Tumor Suppressor and Oncoprotein.
Lucas LM; Dwivedi V; Senfeld JI; Cullum RL; Mill CP; Piazza JT; Bryant IN; Cook LJ; Miller ST; Lott JH; Kelley CM; Knerr EL; Markham JA; Kaufmann DP; Jacobi MA; Shen J; Riese DJ
Pharmacol Rev; 2022 Jan; 74(1):18-47. PubMed ID: 34987087
[TBL] [Abstract] [Full Text] [Related]
3. Molecular insight into the affinity, specificity and cross-reactivity of systematic hepatocellular carcinoma RALT interaction profile with human receptor tyrosine kinases.
Lu G; Li X; Zhang J; Xu Q
Amino Acids; 2021 Nov; 53(11):1715-1728. PubMed ID: 34618235
[TBL] [Abstract] [Full Text] [Related]
4. Molecular Biology Networks and Key Gene Regulators for Inflammatory Biomarkers Shared by Breast cancer Development: Multi-Omics Systems Analysis.
Jung SY; Papp JC; Pellegrini M; Yu H; Sobel EM
Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572592
[TBL] [Abstract] [Full Text] [Related]
5. miR-93-5p knockdown repressed hepatocellular carcinoma progression via increasing erbb4 and TETs-dependent DNA demethylation.
Li Y; Wu B; Sun R; Zhao M; Li N
Autoimmunity; 2021 Dec; 54(8):547-560. PubMed ID: 34435526
[TBL] [Abstract] [Full Text] [Related]
6. Human epidermal growth factor receptor 2-positive metastatic breast cancer with novel epidermal growth factor receptor -ZNF880 fusion and epidermal growth factor receptor E114K mutations effectively treated with pyrotinib: A case report.
Yue L; Wentao L; Xin Z; Jingjing H; Xiaoyan Z; Na F; Tonghui M; Dalin L
Medicine (Baltimore); 2020 Dec; 99(51):e23406. PubMed ID: 33371069
[TBL] [Abstract] [Full Text] [Related]
7. The safety and efficacy of balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma refractory to conventional transcatheter arterial chemoembolization.
Kim PH; Gwon DI; Kim JW; Chu HH; Kim JH
Eur Radiol; 2020 Oct; 30(10):5650-5662. PubMed ID: 32409860
[TBL] [Abstract] [Full Text] [Related]
8. Adjuvant transarterial chemoembolization for patients with hepatocellular carcinoma after radical hepatectomy: a real world study.
Wang L; Ke Q; Deng M; Huang X; Zeng J; Liu H; Yang Y; Zeng Y; Zhou W; Liu J
Scand J Gastroenterol; 2019 Nov; 54(11):1403-1411. PubMed ID: 31686555
[No Abstract] [Full Text] [Related]
9. Integration of Comprehensive Genomic Analysis and Functional Screening of Affected Molecular Pathways to Inform cancer Therapy.
Vasmatzis G; Liu MC; Reganti S; Feathers RW; Smadbeck J; Johnson SH; Schaefer Klein JL; Harris FR; Yang L; Kosari F; Murphy SJ; Borad MJ; Thompson EA; Cheville JC; Anastasiadis PZ
Mayo Clin Proc; 2020 Feb; 95(2):306-318. PubMed ID: 31685261
[TBL] [Abstract] [Full Text] [Related]
10. Induction of nuclear protein-1 by thyroid hormone enhances platelet-derived growth factor A mediated angiogenesis in liver cancer.
Chen CY; Wu SM; Lin YH; Chi HC; Lin SL; Yeh CT; Chuang WY; Lin KH
Theranostics; 2019; 9(8):2361-2379. PubMed ID: 31149049
[No Abstract] [Full Text] [Related]
11. Molecular profiling of the biphasic components of hepatic carcinosarcoma by the use of targeted next-generation sequencing.
Zhang X; Bai Q; Xu Y; Wang W; Chen L; Han J; Zhu H; Zhang Z; Hou Y; Zhou J; Zhou Y; Ji Y
Histopathology; 2019 May; 74(6):944-958. PubMed ID: 30629754
[TBL] [Abstract] [Full Text] [Related]
12. Neratinib in HER2-Positive Breast cancer Patients.
Paranjpe R; Basatneh D; Tao G; De Angelis C; Noormohammed S; Ekinci E; Abughosh S; Ghose R; Trivedi MV
Ann Pharmacother; 2019 Jun; 53(6):612-620. PubMed ID: 30607980
[TBL] [Abstract] [Full Text] [Related]
13. erbb4 acts as a suppressor in colitis and its associated carcinoma by negatively regulating cholesterol metabolism.
Ni H; Chen L; Song L; Sun L; Cui H; Zhou Q; Hu C; Jiao W; Shen T; Gao T; Liu Y; Li J
Carcinogenesis; 2019 Jul; 40(5):680-686. PubMed ID: 30452622
[TBL] [Abstract] [Full Text] [Related]
14. General paucity of genomic alteration and low tumor mutation burden in refractory and metastatic hepatoblastoma: comprehensive genomic profiling study.
Lee H; El Jabbour T; Ainechi S; Gay LM; Elvin JA; Vergilio JA; Suh J; Ramkissoon SH; Ali SM; Schrock A; Fabrizio D; Frampton G; Nazeer T; Miller VA; Stephens PJ; Ross JS
Hum Pathol; 2017 Dec; 70():84-91. PubMed ID: 29079173
[TBL] [Abstract] [Full Text] [Related]
15. Role of ErbB/HER family of receptor tyrosine kinases in cholangiocyte biology.
Pellat A; Vaquero J; Fouassier L
Hepatology; 2018 Feb; 67(2):762-773. PubMed ID: 28671339
[TBL] [Abstract] [Full Text] [Related]
16. A putative molecular network associated with colon cancer metastasis constructed from microarray data.
Chu S; Wang H; Yu M
World J Surg Oncol; 2017 Jun; 15(1):115. PubMed ID: 28629469
[TBL] [Abstract] [Full Text] [Related]
17. erbb4 acts as a suppressor in the development of hepatocellular carcinoma.
Liu Y; Song L; Ni H; Sun L; Jiao W; Chen L; Zhou Q; Shen T; Cui H; Gao T; Li J
Carcinogenesis; 2017 Apr; 38(4):465-473. PubMed ID: 28334319
[TBL] [Abstract] [Full Text] [Related]
18. High-dose radiotherapy is associated with better local control of bone metastasis from hepatocellular carcinoma.
Jung IH; Yoon SM; Kwak J; Park JH; Song SY; Lee SW; Ahn SD; Choi EK; Kim JH
Oncotarget; 2017 Feb; 8(9):15182-15192. PubMed ID: 28146433
[TBL] [Abstract] [Full Text] [Related]
19. Loss of EGFR-ASAP1 signaling in metastatic and unresectable hepatoblastoma.
Ranganathan S; Ningappa M; Ashokkumar C; Higgs BW; Min J; Sun Q; Schmitt L; Subramaniam S; Hakonarson H; Sindhi R
Sci Rep; 2016 Dec; 6():38347. PubMed ID: 27910913
[TBL] [Abstract] [Full Text] [Related]
20. Successful treatment with afatinib after gefitinib- and erlotinib-induced hepatotoxicity.
Ueda H; Hayashi H; Kudo K; Takeda M; Nakagawa K
Invest New Drugs; 2016 Dec; 34(6):797-799. PubMed ID: 27550238
[TBL] [Abstract] [Full Text] [Related]
[Next]
